Free Trial
NASDAQ:AEZS

Aeterna Zentaris (AEZS) Stock Price, News & Analysis

Aeterna Zentaris logo
$3.44 +0.03 (+0.88%)
As of 07/7/2025

About Aeterna Zentaris Stock (NASDAQ:AEZS)

Key Stats

Today's Range
$3.42
$3.46
50-Day Range
$3.30
$3.90
52-Week Range
$3.96
$12.00
Volume
4,112 shs
Average Volume
7,305 shs
Market Capitalization
$6.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AEZS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aeterna Zentaris and its competitors with MarketBeat's FREE daily newsletter.

AEZS Stock News Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
CSCI:CA COSCIENS Biopharma Inc.
Chimerix Inc (CXF.BE)
See More Headlines

AEZS Stock Analysis - Frequently Asked Questions

Aeterna Zentaris' stock was trading at $2.77 on January 1st, 2025. Since then, AEZS stock has increased by 24.2% and is now trading at $3.44.

Aeterna Zentaris Inc. (NASDAQ:AEZS) announced its earnings results on Thursday, November, 4th. The biopharmaceutical company reported ($1.00) EPS for the quarter, beating analysts' consensus estimates of ($2.00) by $1.00. The biopharmaceutical company earned $0.60 million during the quarter, compared to analyst estimates of $0.60 million. Aeterna Zentaris had a negative trailing twelve-month return on equity of 83.45% and a negative net margin of 760.32%.

Aeterna Zentaris shares reverse split on Friday, May 3rd 2024.The 1-4 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Shares of AEZS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aeterna Zentaris investors own include Tonix Pharmaceuticals (TNXP), Bausch Health Cos (BHC), Ford Motor (F), DarioHealth (DRIO), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and Meta Platforms (META).

Company Calendar

Last Earnings
11/04/2021
Today
7/08/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:AEZS
CIK
1113423
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.55 million
Net Margins
-760.32%
Pretax Margin
-760.28%

Debt

Sales & Book Value

Annual Sales
$2.37 million
Price / Cash Flow
N/A
Book Value
$14.99 per share
Price / Book
0.23

Miscellaneous

Free Float
1,791,000
Market Cap
$6.17 million
Optionable
No Data
Beta
1.55

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:AEZS) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners